-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$8.50142.17% Upside
Arbutus Biopharma Corporation Frequently Asked Questions
-
What analysts cover Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation has been rated by research analysts at H.C. Wainwright in the past 90 days.